Skip to content

Outcomes of cold and compression therapy following anterior cruciate ligament reconstruction.

Comparison of outcomes when using an ice pack or electronic cryocompression device following ACL reconstruction: a randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN67880512
Enrollment
52
Registered
2024-10-17
Start date
2026-03-10
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of clinical outcomes following ACL reconstructive surgery Surgery

Interventions

This study is a single-centre randomized controlled trial involving two groups with one receiving cryocompression treatments using a Physiolab S1 cryocompression device and the other group using ice p

Sponsors

Hampshire Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 150 Years

Inclusion criteria

Inclusion criteria: 1. Adult patients of the 3 participating surgeons 2. Scheduled for unilateral ACL reconstruction surgery Patients with any of the below relative contraindications for cryotherapy may be included in the study but will be closely monitored during and immediately following cryotherapy treatments. Any adverse events that are identified will result in the immediate cessation of treatment and removal of that patient from the study. Relative contraindications include: 1. Diabetes 2. A loss of sensation in the intended therapy area 3. Confirmed or suspected tissue infection in the treatment area 4. History of frostbite on the affected limb or therapy area 5. An unstable fracture in the treatment area 6. An unstable localised skin condition in the intended therapy area 7. Heart failure 8. Raynaud’s phenomenon or cold hypersensitivity

Exclusion criteria

Exclusion criteria: 1. Undergoing additional ligament procedure(s) simultaneously 2. Cold urticaria/allergy 3. Known haematological condition that affects clotting 4. Regenerating nerves under the intended therapy area 5. Tissues affected by tuberculosis in the intended therapy area 6. Current or suspected deep vein thrombosis and/or pulmonary embolus 7. Nervous system damage causing muscle tightness with a reduced ability to stretch 8. Cognitive impairment/disabilities or communication barriers 9. Significantly impaired circulation in the intended therapy area 10. Chronic wounds near the intended therapy area 11. Malignant tumour in the affected limb or therapy area 12. Haemorrhaging tissue or any untreated haemorrhagic disorders

Design outcomes

Primary

MeasureTime frame
Subjective pain measured using a numerical pain rating scale at baseline and post-op days 0, 1, 7 and 14

Secondary

MeasureTime frame
1. Satisfaction with the surgery measured using a 5-point Likert scale to respond to the question "Overall, how would you rate the early result of your ACL reconstruction?" with options ranging from "Terrible" to "Excellent" at postoperative days 0, 1, 7 and 14 2. Satisfaction with the cryotherapy measured using a 5-point Likert scale to respond to the question "Overall, how satisfied are you with the cryotherapy treatments you have received today?" with options ranging from "Very unsatisfied" to "Very satisfied" at postoperative days 0, 1, 7 and 14 3. Ease-of-use of Physiolab S1 device (experimental group only) measured using a 5-point Likert scale to respond to the question "Overall, how easy have you found the Physiolab S1 device to use?" with options ranging from "Very difficult" to "Very easy" at postoperative days 0, 1, 7 and 14 4. Complications measured using hospital records following each participant's 14th postoperative day 5. Protocol adherence measured using a self-reported log of cryotherapy treatment frequency, time, method, and settings (where relevant) recorded daily for the first 14 postoperative days. 6. Use-of-analgesia measured using a self-reported log of any analgesic medication taken (time, type, dosage) recorded daily for the first 14 postoperative days

Countries

England, United Kingdom

Contacts

Public ContactJames Belsey
KneeResearch@pm.me+44 (0)7799040556

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 27, 2026